MedPath

se of low vision devices (magnifying lenses) to improve compliance in children on occlusion treatment for lazy eye

Phase 1
Conditions
Health Condition 1: H545- Low vision, one eye
Registration Number
CTRI/2019/02/017596
Lead Sponsor
Christian Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children 5 to 18 years with unilateral amblyopia

Exclusion Criteria

Children who are unable to handle low vision aids

Children unable to come for 1 and 6 months follow up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in compliance with occlusion therapy using LVDTimepoint: Upto six months after good compliance is acheived
Secondary Outcome Measures
NameTimeMethod
Improvement in occlusion therapy for amblyopia in children with counseling alone. <br/ ><br>Improvement in visual acuity in the amblyopic eye . <br/ ><br>Timepoint: Upto six months after good compliance is acheived
© Copyright 2025. All Rights Reserved by MedPath